RadNet stock: growth
RDNTRadNet reported $2.04B in revenue for fiscal 2025, up 11.5% on the prior year, up 13.7% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2005 | |
|---|---|---|---|
| Revenue | 13.7% | 9.7% | 14.3% |
| Revenue per share | 5.2% | 3.9% | 6.9% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | −4.6% | no data | 27.9% |
| Free cash flow per share | −11.8% | no data | 19.6% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2005 | $161.01M | −$6.89M | $799K |
| 2007 | $425.47M | −$18.13M | −$16.47M |
| 2008 | $502.12M | −$12.84M | −$12.86M |
| 2009 | $524.37M | −$2.27M | $39.78M |
| 2010 | $548.54M | −$12.85M | −$35.18M |
| 2011 | $619.8M | $7.23M | −$28.07M |
| 2012 | $647.15M | $64.52M | −$16.03M |
| 2013 | $702.99M | $2.12M | $10.58M |
| 2014 | $717.57M | $1.38M | $9.84M |
| 2015 | $809.63M | $7.71M | −$66.72M |
| 2016 | $884.54M | $7.23M | $25.71M |
| 2017 | $922.19M | $53K | $52.24M |
| 2018 | $975.15M | $32.24M | −$28.62M |
| 2019 | $1.15B | $14.76M | $3.02M |
| 2020 | $1.07B | −$14.84M | $108.32M |
| 2021 | $1.32B | $24.73M | −$71.2M |
| 2022 | $1.43B | $10.65M | −$103M |
| 2023 | $1.62B | $3.04M | $44.26M |
| 2024 | $1.83B | $2.79M | $44.95M |
| 2025 | $2.04B | −$18.65M | $85.57M |
Revenue by segment
How RadNet, Inc. makes its money and how that has shifted. Names are as the company reports them.
- Commercial Insurance155%
- Medicare123%
- Capitation Arrangements6%
- Health Care, Other3%
- Medicaid13%
- Workers' Compensation/Personal Injury12%
- Other7%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies.
Figures as a table
| 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|
| Commercial Insurance1 | $785.13M | $897.95M | $1.02B | $1.13B | 55.4% |
| Medicare1 | $311.12M | $363.86M | $410.07M | $476.99M | 23.4% |
| Capitation Arrangements | $152.05M | $153.43M | $136.58M | $125.54M | 6.2% |
| Health Care, Other | $19.43M | $20.11M | $46.72M | $65.02M | 3.2% |
| Medicaid1 | $38.28M | $43.18M | $44.74M | $51.74M | 2.5% |
| Workers' Compensation/Personal Injury1 | $51.34M | $47.36M | $43.67M | $44.7M | 2.2% |
| Other | $72.72M | $90.74M | $129.56M | $146.12M | 7.2% |
| Total revenue | $1.43B | $1.62B | $1.83B | $2.04B | 100% |
Revenue by region
Where RadNet, Inc. generates its revenue.
- United States98%
- Outside the US2%
- Other< 1%
“Other” combines smaller regions with revenue the company does not assign to a region.
Figures as a table
| 2024 | 2025 | Share 2025 | |
|---|---|---|---|
| United States | $1.8B | $2.01B | 98.3% |
| Outside the US | no data | $33.97M | 1.7% |
| Other | $27.24M | $0 | 0% |
| Total revenue | $1.83B | $2.04B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Jun 2024)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.
